| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledging Patient Heterogeneity in Economic Evaluation
|
Grutters, Janneke P. C.
|
|
2012
|
31 |
2 |
p. 111-123
|
artikel
|
| 2 |
A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination
|
Szucs, Thomas D.
|
|
|
31 |
2 |
p. 125-136
|
artikel
|
| 3 |
A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination
|
Szucs, Thomas D.
|
|
2013
|
31 |
2 |
p. 125-136
|
artikel
|
| 4 |
Comparing Subsidized Access to Medicines Across Payer Systems
|
Wonder, Michael
|
|
2012
|
31 |
2 |
p. 173-174
|
artikel
|
| 5 |
Cost-Effectiveness Acceptability Curves Revisited
|
Al, Maiwenn J.
|
|
2012
|
31 |
2 |
p. 93-100
|
artikel
|
| 6 |
Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling
|
Asukai, Yumi
|
|
2012
|
31 |
2 |
p. 151-161
|
artikel
|
| 7 |
Retigabine for the Adjunctive Treatment of Adults with Partial-Onset Seizures in Epilepsy with and without Secondary Generalization
|
Craig, Dawn
|
|
2013
|
31 |
2 |
p. 101-110
|
artikel
|
| 8 |
The Authors’ Reply to Wonder and Milne: “Comparing Subsidized Access to Medicines Across Payer Systems”
|
Ragupathy, Rajan
|
|
2012
|
31 |
2 |
p. 175-176
|
artikel
|
| 9 |
Valuing Benefits to Inform a Clinical Trial in Pharmacy
|
Tinelli, Michela
|
|
2012
|
31 |
2 |
p. 163-171
|
artikel
|
| 10 |
When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development?
|
Longworth, Louise
|
|
2012
|
31 |
2 |
p. 137-149
|
artikel
|
Tijdschrift beschrijving